Dr. Jeanne M. Marrazzo has been named director of the National Institute of Health, National Institute of Allergy and Infectious Diseases (NIAID), succeeding Dr. Anthony Fauci who has retired. 

Dr. Lawrence A. Tabak, acting director of NIH stated, “Dr. Marrazzo brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organizational budget that includes research funding and mentoring trainees in all stages of professional development.”

As the director of NIAID, Dr. Marrazzo will oversee a budget of $6.3 billion supporting research in the areas of diagnosis and treatment of infectious and immunologic diseases. The institute supports research in 21 laboratories and participates in collaborative research worldwide.

Dr. Marrazzo earned her MD degree from Jefferson Medical College in 1988 and interned at Yale-New Haven Hospital followed by a fellowship at the University of Washington.  She is board certified in infectious disease and is a member of numerous professional medical associations.  She is currently the Director of the Division of Infectious Diseases at the University of Alabama in Birmingham.  Her research includes Group B meningococcal vaccines, and gynecological infections.  She has been a principal investigator on NIH grants since 1997 and is a peer reviewer and advisory committee member for NIAD.

In announcing the appointment, Dr. Tabak complimented Dr. Hugh Auchincloss for serving as Acting Director since December 2022.